{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:52:14Z","timestamp":1781592734006,"version":"3.54.5"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12664-025-01845-w","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:01:39Z","timestamp":1766095299000},"page":"647-665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Altered molecular signature of the intestinal microbiota in irritable bowel syndrome patients versus healthy controls: An updated systematic review"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9449-2338","authenticated-orcid":false,"given":"Zhen-Zhi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"1845_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fphar.2020.00332","volume":"11","author":"B Li","year":"2020","unstructured":"Li B, Liang L, Deng H, Guo J, Shu H, Zhang L. Efficacy and safety of probiotics in irritable bowel syndrome: a systematic review and meta-analysis. Front Pharmacol. 2020;11:332.","journal-title":"Front Pharmacol."},{"key":"1845_CR2","doi-asserted-by":"crossref","unstructured":"Mack A, Bobardt JS, Ha\u00df A, Nichols KB, Schmid RM, Stein-Thoeringer CK. Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort. Gut Microbes. 2020;11:620\u201331","DOI":"10.1080\/19490976.2019.1686322"},{"key":"1845_CR3","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1136\/gutjnl-2019-319630","volume":"69","author":"M El-Salhy","year":"2020","unstructured":"El-Salhy M, Hatlebakk JG, Gilja OH, Br\u00e5then Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020;69:859\u201367.","journal-title":"Gut"},{"key":"1845_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01153","volume":"11","author":"D Maseda","year":"2020","unstructured":"Maseda D, Ricciotti E. NSAID\u2013gut microbiota interactions. Front Pharmacol. 2020;11: 1153.","journal-title":"Front Pharmacol"},{"key":"1845_CR5","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.chom.2020.08.003","volume":"28","author":"AC Gregory","year":"2020","unstructured":"Gregory AC, Zablocki O, Zayed AA, Howell A, Bolduc B, Sullivan MB. The gut virome database reveals age-dependent patterns of virome diversity in the human gut. Cell Host Microbe. 2020;28:724-40.e8.","journal-title":"Cell Host Microbe"},{"key":"1845_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41398-020-0719-8","volume":"10","author":"J Xiao","year":"2020","unstructured":"Xiao J, Wang T, Xu Y, et al. Long-term probiotic intervention mitigates memory dysfunction through a novel H3K27me3-based mechanism in lead-exposed rats. Transl Psychiatry. 2020;10:25.","journal-title":"Transl Psychiatry"},{"key":"1845_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/19490976.2017.1290756","volume":"8","author":"HD Holscher","year":"2017","unstructured":"Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017;8:172\u201384.","journal-title":"Gut Microbes"},{"key":"1845_CR8","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.3389\/fmicb.2020.01058","volume":"11","author":"R Chong","year":"2020","unstructured":"Chong R, Cheng Y, Hogg CJ, Belov K. Marsupial gut microbiome. Front Microbiol. 2020;11:1058.","journal-title":"Front Microbiol"},{"key":"1845_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01935","volume":"8","author":"N Tasnim","year":"2017","unstructured":"Tasnim N, Abulizi N, Pither J, Hart MM, Gibson DL. Linking the gut microbial ecosystem with the environment: does gut health depend on where we live? Front Microbiol. 2017;8: 1935.","journal-title":"Front Microbiol"},{"key":"1845_CR10","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.4014\/jmb.1906.06064","volume":"29","author":"SK Kim","year":"2019","unstructured":"Kim SK, Guevarra RB, Kim YT, et al. Role of probiotics in human gut microbiome-associated diseases. J Microbiol Biotechnol. 2019;29:1335\u201340.","journal-title":"J Microbiol Biotechnol."},{"key":"1845_CR11","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000012","volume":"10","author":"R Duan","year":"2019","unstructured":"Duan R, Zhu S, Wang B, Duan L. Alterations of gut microbiota in patients with irritable bowel syndrome based on 16S rRNA-targeted sequencing: a systematic review. Clin Transl Gastroenterol. 2019;10: e00012.","journal-title":"Clin Transl Gastroenterol"},{"key":"1845_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.603476","volume":"11","author":"M Chen","year":"2020","unstructured":"Chen M, Ding Y, Tong Z. Efficacy and safety of Sophora flavescens (Kushen) based traditional Chinese medicine in the treatment of ulcerative colitis: clinical evidence and potential mechanisms. Front Pharmacol. 2020;11: 603476.","journal-title":"Front Pharmacol"},{"key":"1845_CR13","doi-asserted-by":"publisher","first-page":"572858","DOI":"10.3389\/fimmu.2020.572858","volume":"11","author":"A Paradowska-Gorycka","year":"2020","unstructured":"Paradowska-Gorycka A, Wajda A, Romanowska-Pr\u00f3chnicka K, et al. Th17\/Treg-related transcriptional factor expression and cytokine profile in patients with rheumatoid arthritis. Front Immunol. 2020;11:572858.","journal-title":"Front Immunol."},{"key":"1845_CR14","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.3748\/wjg.v25.i34.5134","volume":"25","author":"X-Y Zhao","year":"2019","unstructured":"Zhao X-Y, Wang J-W, Yin Y, Li K, Zhang M, Yan F-P. Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats. World J Gastroenterol. 2019;25:5134\u201351.","journal-title":"World J Gastroenterol"},{"key":"1845_CR15","doi-asserted-by":"publisher","first-page":"6759","DOI":"10.3748\/wjg.v20.i22.6759","volume":"20","author":"L Saha","year":"2014","unstructured":"Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014;20:6759\u201373.","journal-title":"World J Gastroenterol"},{"key":"1845_CR16","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/19490976.2016.1215805","volume":"7","author":"N Zeber-Lubecka","year":"2016","unstructured":"Zeber-Lubecka N, Kulecka M, Ambrozkiewicz F, et al. Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome. Gut Microbes. 2016;7:397\u2013413.","journal-title":"Gut Microbes."},{"key":"1845_CR17","doi-asserted-by":"publisher","first-page":"13521","DOI":"10.3748\/wjg.v20.i37.13521","volume":"20","author":"X-F Cui","year":"2014","unstructured":"Cui X-F, Zhou W-M, Yang Y, et al. Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome. World J Gastroenterol. 2014;20:13521\u20139.","journal-title":"World J Gastroenterol."},{"key":"1845_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bpj.2018.06.008","volume":"115","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Gao J, Huang Y, Wang J. Recent developments in single-cell RNA-Seq of microorganisms. Biophys J. 2018;115:173\u201380.","journal-title":"Biophys J"},{"key":"1845_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fmicb.2013.00278","volume":"4","author":"H Tsukagoshi","year":"2013","unstructured":"Tsukagoshi H, Ishioka T, Noda M, Kozawa K, Kimura H. Molecular epidemiology of respiratory viruses in virus-induced asthma. Front Microbiol. 2013;4:278.","journal-title":"Front Microbiol"},{"key":"1845_CR20","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","DOI":"10.1136\/bmj.n71"},{"key":"1845_CR21","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","volume":"8","author":"X Zeng","year":"2015","unstructured":"Zeng X, Zhang Y, Kwong JS, et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8:2\u201310.","journal-title":"J Evid Based Med."},{"key":"1845_CR22","doi-asserted-by":"crossref","unstructured":"Talley NJ, Alexander JL, Walker MM, et al. Ileocolonic histopathological and microbial alterations in the irritable bowel syndrome: a nested community case-control study. Clin Transl Gastroenterol. 2020;12:e00296.","DOI":"10.14309\/ctg.0000000000000296"},{"key":"1845_CR23","doi-asserted-by":"publisher","first-page":"2157697","DOI":"10.1080\/19490976.2022.2157697","volume":"15","author":"Q Su","year":"2023","unstructured":"Su Q, Tun HM, Liu Q, et al. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome. Gut Microbes. 2023;15:2157697.","journal-title":"Gut Microbes."},{"key":"1845_CR24","doi-asserted-by":"crossref","unstructured":"Zhu X, Hong G, Li Y, et al. Understanding of the site-specific microbial patterns towards accurate identification for patients with diarrhea-predominant irritable bowel syndrome. Microbiol Spectr. 2021;9:e0125521.","DOI":"10.1128\/Spectrum.01255-21"},{"key":"1845_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1365-2982.2011.01803.x","volume":"24","author":"GC Parkes","year":"2012","unstructured":"Parkes GC, Rayment NB, Hudspith BN, et al. Distinct microbial populations exist in the mucosa-associated microbiota of subgroups of irritable bowel syndrome. Neurogastroenterol Motil. 2012;24:31\u20139.","journal-title":"Neurogastroenterol Motil."},{"key":"1845_CR26","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s10620-009-0934-x","volume":"55","author":"C Codling","year":"2010","unstructured":"Codling C, O\u2019Mahony L, Shanahan F, Quigley EM, Marchesi JR. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome. Dig Dis Sci. 2010;55:392\u20137.","journal-title":"Dig Dis Sci."},{"key":"1845_CR27","doi-asserted-by":"crossref","unstructured":"Hong G, Li Y, Yang M, et al. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: an explorative study. Neurogastroenterol Motil. 2020;32:e13891.","DOI":"10.1111\/nmo.13891"},{"key":"1845_CR28","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1007\/s10620-018-5086-4","volume":"63","author":"N Maharshak","year":"2018","unstructured":"Maharshak N, Ringel Y, Katibian D, et al. Fecal and mucosa-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Dig Dis Sci. 2018;63:1890\u20139.","journal-title":"Dig Dis Sci."},{"key":"1845_CR29","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1038\/ismej.2014.258","volume":"9","author":"V Shankar","year":"2015","unstructured":"Shankar V, Homer D, Rigsbee L, et al. The networks of human gut microbe-metabolite associations are different between health and irritable bowel syndrome. ISME J. 2015;9:1899\u2013903.","journal-title":"ISME J."},{"key":"1845_CR30","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/gutjnl-2020-321466","volume":"70","author":"KS Jabbar","year":"2021","unstructured":"Jabbar KS, Dolan B, Eklund L, et al. Association between Brachyspira and irritable bowel syndrome with diarrhoea. Gut. 2021;70:1117\u201329.","journal-title":"Gut."},{"key":"1845_CR31","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/gutjnl-2018-316502","volume":"68","author":"F Frost","year":"2019","unstructured":"Frost F, Kacprowski T, R\u00fchlemann MC, et al. Functional abdominal pain and discomfort (IBS) is not associated with faecal microbiota composition in the general population. Gut. 2019;68:1131\u20133.","journal-title":"Gut."},{"key":"1845_CR32","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02125-22","volume":"11","author":"G-H Kim","year":"2023","unstructured":"Kim G-H, Lee K, Shim JO. Gut bacterial dysbiosis in irritable bowel syndrome: a case-control study and a cross-cohort analysis using publicly available data sets. Microbiol Spectr. 2023;11: e0212522.","journal-title":"Microbiol Spectr"},{"key":"1845_CR33","doi-asserted-by":"crossref","unstructured":"Chen J, Lan H, Li C, et al. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives. J Appl Microbiol. 2024;135:lxae118.","DOI":"10.1093\/jambio\/lxae118"},{"key":"1845_CR34","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3389\/fcimb.2019.00346","volume":"18","author":"S Zhu","year":"2019","unstructured":"Zhu S, Liu S, Li H, et al. Identification of gut microbiota and metabolites signature in patients with irritable bowel syndrome. Front Cell Infect Microbiol. 2019;18:346.","journal-title":"Front Cell Infect Microbiol."},{"key":"1845_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01600","volume":"9","author":"X Zhuang","year":"2018","unstructured":"Zhuang X, Tian Z, Li L, Zeng Z, Chen M, Xiong L. Fecal microbiota alterations associated with diarrhea-predominant irritable bowel syndrome. Front Microbiol. 2018;9: 1600.","journal-title":"Front Microbiol"},{"key":"1845_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13099-021-00406-8","volume":"13","author":"S Jandee","year":"2021","unstructured":"Jandee S, Chuensakul S, Maneerat S. No distinction in the gut microbiota between diarrhea predominant-irritable bowel syndrome and healthy subjects: matched case-control study in Thailand. Gut Pathog. 2021;13:16.","journal-title":"Gut Pathog"},{"key":"1845_CR37","doi-asserted-by":"publisher","first-page":"515614","DOI":"10.3389\/fcimb.2020.515614","volume":"2","author":"M Yang","year":"2020","unstructured":"Yang M, Hong G, Jin Y, Li Y, Li G, Hou X. Mucosal-associated microbiota other than luminal microbiota has a close relationship with diarrhea-predominant irritable bowel syndrome. Front Cell Infect Microbiol. 2020;2:515614.","journal-title":"Front Cell Infect Microbiol."},{"key":"1845_CR38","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1053\/j.gastro.2017.06.004","volume":"153","author":"S Botschuijver","year":"2017","unstructured":"Botschuijver S, Roeselers G, Levin E, et al. Intestinal fungal dysbiosis is associated with visceral hypersensitivity in patients with irritable bowel syndrome and rats. Gastroenterology. 2017;153:1026\u201339.","journal-title":"Gastroenterology."},{"key":"1845_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1757-4749-2-19","volume":"2","author":"IM Carroll","year":"2010","unstructured":"Carroll IM, Chang YH, Park J, Sartor RB, Ringel Y. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog. 2010;2:19.","journal-title":"Gut Pathog."},{"key":"1845_CR40","doi-asserted-by":"publisher","first-page":"G799","DOI":"10.1152\/ajpgi.00154.2011","volume":"301","author":"IM Carroll","year":"2011","unstructured":"Carroll IM, Ringel-Kulka T, Keku TO, et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2011;301:G799-807.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1845_CR41","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1365-2036.2012.05007.x","volume":"35","author":"C Chassard","year":"2012","unstructured":"Chassard C, Dapoigny M, Scott KP, et al. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome. Aliment Pharmacol Ther. 2012;35:828\u201338.","journal-title":"Aliment Pharmacol Ther."},{"key":"1845_CR42","first-page":"238","volume":"5","author":"S Cui","year":"2012","unstructured":"Cui S, Hu Y. Multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study. Int J Clin Exp Med. 2012;5:238\u201344.","journal-title":"Int J Clin Exp Med"},{"issue":"513\u201320","key":"1845_CR43","first-page":"e246","volume":"24","author":"H Duboc","year":"2012","unstructured":"Duboc H, Rainteau D, Rajca S, et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. 2012;24:513\u201320, e246\u20137.","journal-title":"Neurogastroenterol Motil."},{"key":"1845_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1758-2229.2012.00327.x","volume":"4","author":"A Durb\u00e1n","year":"2012","unstructured":"Durb\u00e1n A, Abell\u00e1n JJ, Jim\u00e9nez-Hern\u00e1ndez N, et al. Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome. Environ Microbiol Rep. 2012;4:242\u20137.","journal-title":"Environ Microbiol Rep."},{"key":"1845_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000477205","volume":"36","author":"LR Lopetuso","year":"2018","unstructured":"Lopetuso LR, Petito V, Graziani C, et al. Gut microbiota in health, diverticular disease, irritable bowel syndrome, and inflammatory bowel diseases: time for microbial marker of gastrointestinal disorders. Dig Dis. 2018;36:56\u201365.","journal-title":"Dig Dis."},{"key":"1845_CR46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1572-0241.2005.40312.x","volume":"100","author":"E Malinen","year":"2005","unstructured":"Malinen E, Rinttil\u00e4 T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol. 2005;100:373\u201382.","journal-title":"Am J Gastroenterol."},{"key":"1845_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.femsim.2004.08.009","volume":"43","author":"J M\u00e4tt\u00f6","year":"2005","unstructured":"M\u00e4tt\u00f6 J, Maunuksela L, Kajander K, et al. Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome\u2013a longitudinal study in IBS and control subjects. FEMS Immunol Med Microbiol. 2005;43:213\u201322.","journal-title":"FEMS Immunol Med Microbiol."},{"key":"1845_CR48","first-page":"364","volume":"22","author":"M-R Sheikh Sajjadieh","year":"2012","unstructured":"Sheikh Sajjadieh M-R, Kuznetsova LV, Bojenko VB. Dysbiosis in ukrainian children with irritable bowel syndrome affected by natural radiation. Iran J Pediatr. 2012;22:364\u20138.","journal-title":"Iran J Pediatr"},{"issue":"512\u20139","key":"1845_CR49","first-page":"e114","volume":"22","author":"C Tana","year":"2010","unstructured":"Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010;22:512\u20139, e114\u20135.","journal-title":"Neurogastroenterol Motil."},{"key":"1845_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40168-017-0260-z","volume":"5","author":"JS Labus","year":"2017","unstructured":"Labus JS, Hollister EB, Jacobs J, et al. Differences in gut microbial composition correlate with regional brain volumes in irritable bowel syndrome. Microbiome. 2017;5:49.","journal-title":"Microbiome."},{"key":"1845_CR51","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/j.gastro.2016.09.049","volume":"152","author":"J Tap","year":"2017","unstructured":"Tap J, Derrien M, T\u00f6rnblom H, et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology. 2017;152:111-23.e8.","journal-title":"Gastroenterology."},{"key":"1845_CR52","doi-asserted-by":"publisher","first-page":"39399","DOI":"10.1038\/srep39399","volume":"16","author":"AP Gobert","year":"2016","unstructured":"Gobert AP, Sagrestani G, Delmas E, et al. The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties. Sci Rep. 2016;16:39399.","journal-title":"Sci Rep."},{"key":"1845_CR53","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40168-016-0191-0","volume":"4","author":"R Nagel","year":"2016","unstructured":"Nagel R, Traub RJ, Allcock RJ, Kwan MM, Bielefeldt-Ohmann H. Comparison of faecal microbiota in Blastocystis-positive and Blastocystis-negative irritable bowel syndrome patients. Microbiome. 2016;4:47.","journal-title":"Microbiome."},{"key":"1845_CR54","doi-asserted-by":"publisher","first-page":"G417","DOI":"10.1152\/ajpgi.00044.2015","volume":"310","author":"T Ringel-Kulka","year":"2016","unstructured":"Ringel-Kulka T, Benson AK, Carroll IM, Kim J, Legge RM, Ringel Y. Molecular characterization of the intestinal microbiota in patients with and without abdominal bloating. Am J Physiol Gastrointest Liver Physiol. 2016;310:G417-26.","journal-title":"Am J Physiol Gastrointest Liver Physiol."},{"key":"1845_CR55","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3109\/00365521.2015.1116107","volume":"51","author":"CS Chung","year":"2016","unstructured":"Chung CS, Chang PF, Liao CH, et al. Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects. Scand J Gastroenterol. 2016;51:410\u20139.","journal-title":"Scand J Gastroenterol."},{"key":"1845_CR56","doi-asserted-by":"publisher","first-page":"12693","DOI":"10.1038\/srep12693","volume":"5","author":"M Pozuelo","year":"2015","unstructured":"Pozuelo M, Panda S, Santiago A, et al. Reduction of butyrate- and methane-producing microorganisms in patients with irritable bowel syndrome. Sci Rep. 2015;5:12693.","journal-title":"Sci Rep."},{"key":"1845_CR57","doi-asserted-by":"publisher","first-page":"8508","DOI":"10.1038\/srep08508","volume":"17","author":"A Dlugosz","year":"2015","unstructured":"Dlugosz A, Winckler B, Lundin E, et al. No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls. Sci Rep. 2015;17:8508.","journal-title":"Sci Rep."},{"key":"1845_CR58","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/jgh.12306","volume":"28","author":"SC Ng","year":"2013","unstructured":"Ng SC, Lam EF, Lam TT, et al. Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome. J Gastroenterol Hepatol. 2013;28:1624\u201331.","journal-title":"J Gastroenterol Hepatol."},{"key":"1845_CR59","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1136\/gutjnl-2011-301501","volume":"61","author":"IB Jeffery","year":"2012","unstructured":"Jeffery IB, O\u2019Toole PW, \u00d6hman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2012;61:997\u20131006.","journal-title":"Gut."},{"key":"1845_CR60","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1007\/s10620-015-3607-y","volume":"60","author":"R Shukla","year":"2015","unstructured":"Shukla R, Ghoshal U, Dhole TN, Ghoshal UC. Fecal microbiota in patients with irritable bowel syndrome compared with healthy controls using real-time polymerase chain reaction: an evidence of dysbiosis. Dig Dis Sci. 2015;60:2953\u201362.","journal-title":"Dig Dis Sci"},{"issue":"Pt 2","key":"1845_CR61","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1099\/jmm.0.022848-0","volume":"60","author":"APM Kerckhoffs","year":"2011","unstructured":"Kerckhoffs APM, Ben-Amor K, Samsom M, et al. Molecular analysis of faecal and duodenal samples reveals significantly higher prevalence and numbers of Pseudomonas aeruginosa in irritable bowel syndrome. J Med Microbiol. 2011;60  Pt 2:236\u201345.","journal-title":"J Med Microbiol."},{"key":"1845_CR62","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-230X-9-95","volume":"9","author":"L Krogius-Kurikka","year":"2009","unstructured":"Krogius-Kurikka L, Lyra A, Malinen E, et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 2009;9:95.","journal-title":"BMC Gastroenterol."},{"key":"1845_CR63","doi-asserted-by":"publisher","first-page":"5936","DOI":"10.3748\/wjg.15.5936","volume":"15","author":"A Lyra","year":"2009","unstructured":"Lyra A, Rinttil\u00e4 T, Nikkil\u00e4 J, et al. Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification. World J Gastroenterol. 2009;15:5936\u201345.","journal-title":"World J Gastroenterol."},{"key":"1845_CR64","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3109\/00365521.2015.1027261","volume":"50","author":"E Giamarellos-Bourboulis","year":"2015","unstructured":"Giamarellos-Bourboulis E, Tang J, Pyleris E, et al. Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome. Scand J Gastroenterol. 2015;50:1076\u201387.","journal-title":"Scand J Gastroenterol."},{"key":"1845_CR65","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ebiom.2015.07.007","volume":"2","author":"C Zhang","year":"2015","unstructured":"Zhang C, Yin A, Li H, et al. Dietary modulation of gut microbiota contributes to alleviation of both genetic and simple obesity in children. EBioMedicine. 2015;2:968\u201384.","journal-title":"EBioMedicine."},{"key":"1845_CR66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12876-021-01693-w","volume":"21","author":"L Mei","year":"2021","unstructured":"Mei L, Zhou J, Su Y, et al. Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol. 2021;21:105.","journal-title":"BMC Gastroenterol."},{"key":"1845_CR67","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/gutjnl-2019-320438","volume":"69","author":"V Meslier","year":"2020","unstructured":"Meslier V, Laiola M, Roager HM, et al. Mediterranean diet intervention in overweight and obese subjects lowers plasma cholesterol and causes changes in the gut microbiome and metabolome independently of energy intake. Gut. 2020;69:1258\u201368.","journal-title":"Gut."},{"key":"1845_CR68","doi-asserted-by":"publisher","first-page":"2063016","DOI":"10.1080\/19490976.2022.2063016","volume":"14","author":"Z Mujagic","year":"2022","unstructured":"Mujagic Z, Kasapi M, Jonkers DM, et al. Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome. Gut Microbes. 2022;14:2063016.","journal-title":"Gut Microbes."},{"key":"1845_CR69","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1136\/gutjnl-2021-324891","volume":"70","author":"D So","year":"2021","unstructured":"So D, Gibson PR, Muir JG, Yao CK. Dietary fibres and IBS: translating functional characteristics to clinical value in the era of personalised medicine. Gut. 2021;70:2383\u201394.","journal-title":"Gut."},{"key":"1845_CR70","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1163\/18762891-bja00015","volume":"15","author":"KJ Kamp","year":"2024","unstructured":"Kamp KJ, Plantinga AM, Cain KC, et al. Gut microbiome and symptoms in females with irritable bowel syndrome: a cross-sectional analysis. Benef Microbes. 2024;15:259\u201373.","journal-title":"Benef Microbes."},{"key":"1845_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114892","volume":"163","author":"P Petakh","year":"2023","unstructured":"Petakh P, Oksenych V, Kamyshnyi A. The F\/B ratio as a biomarker for inflammation in COVID-19 and T2D: impact of metformin. Biomed Pharmacother. 2023;163: 114892.","journal-title":"Biomed Pharmacother"},{"key":"1845_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00109-016-1492-2","volume":"95","author":"EL Johnson","year":"2017","unstructured":"Johnson EL, Heaver SL, Walters WA, Ley RE. Microbiome and metabolic disease: revisiting the bacterial phylum Bacteroidetes. J Mol Med (Berl). 2017;95:1\u20138.","journal-title":"J Mol Med (Berl)"},{"key":"1845_CR73","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1053\/j.gastro.2011.07.043","volume":"141","author":"M Rajili\u0107-Stojanovi\u0107","year":"2011","unstructured":"Rajili\u0107-Stojanovi\u0107 M, Biagi E, Heilig HGHJ, et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology. 2011;141:1792\u2013801.","journal-title":"Gastroenterology."},{"key":"1845_CR74","doi-asserted-by":"publisher","first-page":"434","DOI":"10.5056\/jnm.2012.18.4.434","volume":"18","author":"V Pokkunuri","year":"2012","unstructured":"Pokkunuri V, Pimentel M, Morales W, et al. Role of cytolethal distending toxin in altered stool form and bowel phenotypes in a rat model of post-infectious irritable bowel syndrome. J Neurogastroenterol Motility. 2012;18:434\u201342.","journal-title":"J Neurogastroenterol Motility."},{"key":"1845_CR75","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s40168-018-0587-0","volume":"6","author":"K Kaliannan","year":"2018","unstructured":"Kaliannan K, Robertson RC, Murphy K, et al. Estrogen-mediated gut microbiome alterations influence sexual dimorphism in metabolic syndrome in mice. Microbiome. 2018;6:205.","journal-title":"Microbiome."},{"key":"1845_CR76","doi-asserted-by":"crossref","unstructured":"Schepper JD, Collins F, Rios-Arce ND, et al. Probiotic Lactobacillus reuteri prevents post-antibiotic bone loss by reducing intestinal dysbiosis and preventing barrier disruption. J Bone Miner Res. 2019;34:681-98.","DOI":"10.1002\/jbmr.3635"},{"key":"1845_CR77","doi-asserted-by":"publisher","first-page":"1756283X1774662","DOI":"10.1177\/1756283X17746625","volume":"11","author":"MJ Torres","year":"2018","unstructured":"Torres MJ, Sabate J-M, Bouchoucha M, Buscail C, Hercberg S, Julia C. Food consumption and dietary intakes in 36,448 adults and their association with irritable bowel syndrome: Nutrinet-Sant\u00e9 study. Ther Adv Gastroenterol. 2018;11:1756283X17746625.","journal-title":"Ther Adv Gastroenterol"},{"key":"1845_CR78","doi-asserted-by":"crossref","unstructured":"Waseem MR, Shin A, Siwiec R, et al. Associations of fecal short chain fatty acids with colonic transit, fecal bile acid, and food intake in irritable bowel syndrome. Clin Transl Gastroenterol. 2023;14:e00541.","DOI":"10.14309\/ctg.0000000000000541"},{"key":"1845_CR79","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.dld.2021.04.022","volume":"53","author":"W Wei","year":"2021","unstructured":"Wei W, Wang H, Zhang Y, et al. Faecal bile acids and colonic bile acid membrane receptor correlate with symptom severity of diarrhoea-predominant irritable bowel syndrome: a pilot study. Dig Liver Dis. 2021;53:1120\u20137.","journal-title":"Dig Liver Dis."},{"key":"1845_CR80","doi-asserted-by":"publisher","first-page":"606","DOI":"10.5056\/jnm16201","volume":"23","author":"NH Kim","year":"2017","unstructured":"Kim NH, Park JH, Park J, Joung Y-H. The effect of deoxycholic acid on secretion and motility in the rat and guinea pig large intestine. J Neurogastroenterol Motil. 2017;23:606\u201315.","journal-title":"J Neurogastroenterol Motil."},{"key":"1845_CR81","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1080\/19490976.2020.1756690","volume":"11","author":"NS Oh","year":"2020","unstructured":"Oh NS, Joung JY, Lee JY, et al. Glycated milk protein fermented with Lactobacillus rhamnosus ameliorates the cognitive health of mice under mild-stress condition. Gut Microbes. 2020;11:1643.","journal-title":"Gut Microbes."},{"key":"1845_CR82","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13099-017-0224-7","volume":"9","author":"N Yusof","year":"2017","unstructured":"Yusof N, Hamid N, Ma ZF, et al. Exposure to environmental microbiota explains persistent abdominal pain and irritable bowel syndrome after a major flood. Gut Pathogens. 2017;9:75.","journal-title":"Gut Pathogens."},{"key":"1845_CR83","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1053\/j.gastro.2017.06.010","volume":"153","author":"HM Staudacher","year":"2017","unstructured":"Staudacher HM, Lomer MCE, Farquharson FM, et al. A diet low in FODMAPs reduces symptoms in patients with irritable bowel syndrome and a probiotic restores Bifidobacterium species: a randomized controlled trial. Gastroenterology. 2017;153:936\u201347.","journal-title":"Gastroenterology."},{"key":"1845_CR84","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/nu16101503","volume":"16","author":"H Sommermeyer","year":"2024","unstructured":"Sommermeyer H, Chmielowiec K, Bernatek M, Olszewski P, Kopczynski J, Pi\u0105tek J. Effectiveness of a balanced nine-strain synbiotic in primary-care irritable bowel syndrome patients-a multi-center, randomized, double-blind, placebo-controlled trial. Nutrients. 2024;16:1503.","journal-title":"Nutrients."},{"key":"1845_CR85","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00406-014-0502-z","volume":"264","author":"G Fond","year":"2014","unstructured":"Fond G, Loundou A, Hamdani N, et al. Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2014;264:651\u201360.","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"key":"1845_CR86","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/apt.12800","volume":"40","author":"T Ringel-Kulka","year":"2014","unstructured":"Ringel-Kulka T, Goldsmith JR, Carroll IM, et al. Randomized clinical trial: Lactobacillus acidophilus NCFM affects colonic mucosal opioid receptors expression in human patients with functional abdominal pain. Aliment Pharmacol Ther. 2014;40:200.","journal-title":"Aliment Pharmacol Ther"},{"key":"1845_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.859967","volume":"12","author":"T Zhang","year":"2022","unstructured":"Zhang T, Zhang C, Zhang J, Sun F, Duan L. Efficacy of probiotics for irritable bowel syndrome: a systematic review and network meta-analysis. Front Cell Infect Microbiol. 2022;12: 859967.","journal-title":"Front Cell Infect Microbiol"},{"key":"1845_CR88","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/apt.15001","volume":"48","author":"AC Ford","year":"2018","unstructured":"Ford AC, Harris LA, Lacy BE, Quigley EMM, Moayyedi P. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018;48:1044\u201360.","journal-title":"Aliment Pharmacol Ther"},{"key":"1845_CR89","doi-asserted-by":"crossref","unstructured":"Shang X, E F-F, Guo K-L, et al. Effectiveness and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 randomized controlled trials. Nutrients. 2022;14:2482","DOI":"10.3390\/nu14122482"},{"key":"1845_CR90","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3748\/wjg.v22.i7.2179","volume":"22","author":"F Durchschein","year":"2016","unstructured":"Durchschein F, Petritsch W, Hammer HF. Diet therapy for inflammatory bowel diseases: the established and the new. World J Gastroenterol. 2016;22:2179\u201394.","journal-title":"World J Gastroenterol"},{"key":"1845_CR91","doi-asserted-by":"publisher","first-page":"1603758","DOI":"10.1155\/2019\/1603758","volume":"2019","author":"W Zeng","year":"2019","unstructured":"Zeng W, Shen J, Bo T, et al. Cutting edge: probiotics and fecal microbiota transplantation in immunomodulation. J Immunol Res. 2019;2019:1603758.","journal-title":"J Immunol Res."},{"key":"1845_CR92","first-page":"1569","volume":"12","author":"H Wang","year":"2020","unstructured":"Wang H, Zhou C, Huang J, Kuai X, Shao X. The potential therapeutic role of Lactobacillus reuteri for treatment of inflammatory bowel disease. Am J Transl Res. 2020;12:1569\u201383.","journal-title":"Am J Transl Res"},{"key":"1845_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01166","volume":"9","author":"M Yu","year":"2018","unstructured":"Yu M, Mu C, Zhang C, Yang Y, Su Y, Zhu W. Marked response in microbial community and metabolism in the ileum and cecum of suckling piglets after early antibiotics exposure. Front Microbiol. 2018;9: 1166.","journal-title":"Front Microbiol"},{"key":"1845_CR94","doi-asserted-by":"publisher","first-page":"658","DOI":"10.4093\/dmj.2019.0220","volume":"44","author":"Y Lee","year":"2020","unstructured":"Lee Y, Lee H-Y. Revisiting the bacterial phylum composition in metabolic diseases focused on host energy metabolism. Diabetes Metab J. 2020;44:658\u201367.","journal-title":"Diabetes Metab J"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01845-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-025-01845-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01845-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:02:20Z","timestamp":1781589740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-025-01845-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1845"],"URL":"https:\/\/doi.org\/10.1007\/s12664-025-01845-w","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"18 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was not required for this systematic review, as it involved the analysis of previously published data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical considerations"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors are solely responsible for the data and the\u00a0contents of the paper. In no way, the Honorary Editor-in-Chief,\u00a0Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for\u00a0the results\/findings and content of this article.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}